Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes
N. Tofte*, M. Lindhardt, K. Adamova, J. Beige, J. W.J. Beulens, A. L. Birkenfeld, G. Currie, C. Delles, I. Dimos, L. Francová, M. Frimodt-Møller, P. Girman, R. Göke, T. Havrdova, A. Kooy, H. Mischak, G. Navis, G. Nijpels, M. Noutsou, A. OrtizA. Parvanova, F. Persson, P. L. Ruggenenti, F. Rutters, I. Rychlík, G. Spasovski, M. Speeckaert, M. Trillini, H. von der Leyen, P. Rossing
Dyk ned i forskningsemnerne om 'Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes'. Sammen danner de et unikt fingeraftryk.